Osteomyelitis Clinical Trial
Official title:
Oral-only Antibiotics for Bone and Joint Infections in Children - A Nationwide Randomized Controlled Trial
A nationwide, multicenter, randomized, non-inferiority trial of children with bone and joint infections. The primary objective is to determine if oral-only antibiotics (experimental arm) is non-inferior to initial intravenous antibiotics followed by oral therapy (control arm). Children will be randomized 1:1. The total treatment duration is identical in both groups. The study is open label with blinding of the primary endpoint assessor.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03846804 -
Next-Generation Sequencing for Pathogen Detection and Quantification in Children With Musculoskeletal Infections
|
N/A | |
| Active, not recruiting |
NCT04945434 -
Clinical Effectiveness of S53P4 Bioactive Glass in Treatment of Long-bone Chronic Osteomyelitis
|
N/A | |
| Recruiting |
NCT06084754 -
Effect of Pulsed Electromagnetic Field Stimulation on Localized Pediatric Osteomyelitis
|
N/A | |
| Recruiting |
NCT05177107 -
Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis
|
Phase 2 | |
| Recruiting |
NCT04554108 -
Acute Non-severe Osteomyelitis in Children - Outpatient Management Strategy With Oral Antibiotic Therapy Compared to a Standard Strategy With Conventional Hospitalization and Intravenous Antibiotic Therapy: a Randomized Open-label Non-inferiority Study With Bayesian and Medical-economic Analyses.
|
N/A | |
| Recruiting |
NCT02128256 -
CERAMENT™|G - Bone Healing and Re-infection Prophylaxis
|
Phase 4 | |
| Terminated |
NCT01612962 -
Diagnostic Tests to Help Determine Osteomyelitis
|
N/A | |
| Terminated |
NCT03091439 -
Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Patients With Osteomyelitis
|
Phase 2 | |
| Recruiting |
NCT04936958 -
RETR(Osteomyelitis)
|
||
| Completed |
NCT03802552 -
Cefadroxil and Cephalexin Drug Levels and Dosing in Pediatric Musculoskeletal Infections
|
Phase 1 | |
| Completed |
NCT03559530 -
Acinetobacter Baumannii-related Osteomyelitis: Clinical and Epidemiological Characterization
|
||
| Completed |
NCT00324922 -
Vancomycin Or Trimethoprim/Sulfamethoxazole for Methicillin-resistant Staphylococcus Aureus Osteomyelitis
|
Phase 3 | |
| Completed |
NCT02084147 -
PET-MRI in Diagnosing Patients With Cancer, Cardiac Diseases, or Neurologic Diseases
|
N/A | |
| Terminated |
NCT02099240 -
Patients Response to Early Switch To Oral:Osteomyelitis Study
|
Early Phase 1 | |
| Withdrawn |
NCT02344511 -
Dalbavancin vs Comparator in Pediatric Subjects With Acute Hematogenous Osteomyelitis
|
Phase 3 | |
| Completed |
NCT00402064 -
The Influence of Bisphosphonates in the Oral Cavity in Children
|
N/A | |
| Terminated |
NCT02168816 -
Efficacy of Oral Antibiotic Therapy Compared to Intravenous Antibiotic Therapy for Osteomyelitis
|
Phase 2 | |
| Completed |
NCT02685033 -
Study on the Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Participants With Osteomyelitis
|
Phase 2 | |
| Completed |
NCT02335905 -
Ceftaroline for Treatment of Hematogenously Acquired Staphylococcus Aureus Osteomyelitis in Children
|
Phase 1/Phase 2 | |
| Completed |
NCT00428844 -
Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci
|
Phase 2 |